Changing of Prostate Specific Antigen Value in Patients With Covid-19

Not Applicable

• Conditions: Prostate Specific Antigen; Covid19

• Registration Number: NCT05009186
• Lead Sponsor: Saglik Bilimleri Universitesi

Brief Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic in over 100 years. The disease caused by this newly discovered virus was called Covid-19. In this study, we aimed to evaluate changing of PSA value in patients with Covid-19.

Detailed Description

Patients with positive PCR test results were included in the study. The age of the patient and urea, leukocyte, hemoglobin, platelet, urea, and creatinine values of the patients were recorded. Urinalysis and urine culture were taken from all patients. Acute phase reactants such as sedimentation, C-reaktif protein (CRP), ferritin, and fibrinogen were measured both at the time the patients applied and three weeks after the patient recovered. PSA and free PSA were also measured in the same way. Patients whose symptoms improved and the PCR test result was negative were considered as recovered.

Study Timeline

• Study Start: 2020-04-01
• Status Verified: 2021-08
• Study First Submitted: 2021-08-15
• Study First Submitted QC: 2021-08-15
• Last Update Submitted: 2021-08-15
• Study First Posted: 2021-08-17
• Last Update Posted: 2021-08-17
• Primary Completion: 2021-10-01
• Study Completion: 2021-10-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

• Male patients (>45 and <70 years of age) positive PCR test results were included in the study

Exclusion Criteria

• The patients <45 and >70 years of age who described lower urinary tract symptoms who had urinary tract infection who a history of prostate biopsy and previous high level of PSA who history of prostatitis were excluded.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
PSA value	2 months	prostate specific antigen

Secondary Outcome Measures

Name	Time	Method
Ferritin, CRP	2 months

Trial Locations

Locations (1)

Omer Gokhan Doluoglu; 🇹🇷 Ankara, Altindag, Turkey